Unknown

Dataset Information

0

[CMP] [cell line] [SIDM00411] Pancreatic Carcinoma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-CMO264 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins.
| S-EPMC3612900 | biostudies-literature
Proteomics Identification of substrates of ZDHHC20 in a mouse pancreatic carcinoma cell line
2023-02-09 | PXD036914 | Pride
Unknown Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.
| S-EPMC4855772 | biostudies-literature
Unknown Development of a conditionally immortalized human pancreatic β cell line.
| S-EPMC4001549 | biostudies-literature
Unknown Pancreatic tropism of metastatic renal cell carcinoma.
| S-EPMC7205259 | biostudies-literature
Unknown Inhibition of CMP-sialic acid transport by endogenous 5-methyl CMP.
| S-EPMC8174729 | biostudies-literature
Unknown 5'-CMP and 5'-UMP promote myogenic differentiation and mitochondrial biogenesis by activating myogenin and PGC-1α in a mouse myoblast C2C12 cell line.
| S-EPMC9294244 | biostudies-literature
Unknown Phenotypic, Genomic, and Transcriptomic Heterogeneity in a Pancreatic Cancer Cell Line.
| S-EPMC11384550 | biostudies-literature
Unknown Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence.
| S-EPMC4219683 | biostudies-literature
Unknown Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
| S-EPMC6233492 | biostudies-literature